Cariporide inhibits high glucose-mediated adhesion of monocyte-endothelial cell and expression of intercellular adhesion molecule-1

Life Sciences

Volumn 79, Issue 14, 2006, Pages 1399-1404

  Wang, Shuang Xi ^a   Sun, Xue Ying ^a   Zhang, Xiao Hong ^a   Chen, Shuang Xiu ^a   Liu, Yu Hui ^a   Liu, Li Ying ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Adhesion; Cariporide; Endothelial cell; Glucose; ICAM 1

Indexed keywords

CARIPORIDE; GLUCOSE; INTERCELLULAR ADHESION MOLECULE 1; MANNITOL; MERCURY; PROTEIN; PROTEIN INHIBITOR; SODIUM HYDROGEN EXCHANGER 1 INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CELL ADHESION; CELL CULTURE; CELL ISOLATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HYPEROSMOLARITY; INCUBATION TIME; MONOCYTE; PH MEASUREMENT; PROTEIN CONTENT; PROTEIN EXPRESSION; SPECTROFLUOROMETRY;

ANTI-ARRHYTHMIA AGENTS; CATION TRANSPORT PROTEINS; CELL ADHESION; CELLS, CULTURED; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUCOSE; GUANIDINES; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MEMBRANE PROTEINS; MONOCYTES; OSMOLAR CONCENTRATION; SODIUM-HYDROGEN ANTIPORTER; SPECTROMETRY, FLUORESCENCE; SULFONES;

EID: 33747034723     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2006.04.008     Document Type: Article

References (38)

1. Abel E.D. Myocardial insulin resistance and cardiac complications of diabetes. Current Drug Targets. Immune, Endocrine & Metabolic Disorders 5 2 (2005) 219-226
2. Bannan S., Mansfield M.W., and Grant P.J. Soluble vascular cell adhesion molecule-1 and E-selectin levels in relation to vascular risk factors and to E-selectin genotype in the first degree relatives of NIDDM patients and in NIDDM patients. Diabetologia 41 4 (1998) 460-466
3. + exchange in cultured vascular smooth muscle cells: evidence for protein kinase C-dependent and -independent pathways. The Journal of Biological Chemistry 262 11 (1987) 5057-5064
4. Booth G., Stalker T.J., Lefer A.M., and Scalia R. Mechanisms of amelioration of glucose-induced endothelial dysfunction following inhibition of protein kinase C in vivo. Diabetes 51 5 (2002) 1556-1564
5. Ceriello A., Falleti E., Motz E., Taboga C., Tonutti L., Ezsol Z., Gonano F., and Bartoli E. Hyperglycemia-induced circulating ICAM-1 increase in diabetes mellitus: the possible role of oxidative stress. Hormone and Metabolic Research 30 3 (1998) 146-149
6. + exchange hyperactivity and myocardial hypertrophy: are they linked phenomena?. Cardiovascular Research 44 3 (1999) 462-467
7. Cominacini L., Fratta P.A., Garbin U., Davoli A., De S.A., Campagnola M., Rigoni A., Zenti M.G., Moghetti P., and Lo C.V. Elevated level of soluble E-selectin in patient with IDDM and NIDDM: relation to metabolic control. Diabetologia 38 9 (1995) 1122-1124
8. Glowinska B., Urban M., Peczynska J., and Florys B. Soluble adhesion molecules (sICAM-1, sVCAM-1) and selectins (sE selectin, sP selectin, sL selectin) levels in children and adolescents with obesity, hypertension, and diabetes. Metabolism 54 8 (2005) 1020-1026
9. Goldrosen M., Gannon P., Lutz M., and Holyoke E. Isolation of human peripheral blood lymphocytes: modification of a double discontinuous density gradient of Ficoll-Hypaque. Journal of Immunological Methods 14 1 (1997) 15
10. Hattori R., Otani H., Moriguchi Y., Matsubara H., Yamamura T., Nakao Y., Omiya H., Osako M., and Imamura H. NHE and ICAM-1 expression in hypoxic/reoxygenated coronary microvascular endothelial cells. American Journal of Physiology. Heart and Circulatory Physiology 280 6 (2001) H2796-H2803
11. + exchange inhibitor SM-20220 attenuates leukocyte adhesion induced by ischemia-reperfusion. Journal of Cardiovascular Pharmacology 37 6 (2001) 668-677
12. + exchange inhibition. Circulation Research 87 12 (2000) 1133-1140
13. Kaloyianni M., Zolota Z., Paletas K., Tsapas A., and Koliakos G. Cariporide counteracts atherosclerosis-related functions in monocytes from obese and normal individuals. Obesity Research 13 9 (2005) 1588-1595
14. Kim J.A., Berliner J.A., Natarajan R.D., and Nadler J.L. Evidence that glucose increases monocyte binding to human aortic endothelial cells. Diabetes 43 9 (1994) 1103-1107
15. + antiport activity in rat alveolar epithelial cells. American Journal of Physiology 266 2 Pt 1 (1994) L138-L147
16. Mustard J.F., and Packham M.A. Platelets and diabetes mellitus. The New England Journal of Medicine 311 10 (1984) 665-667
17. Omi H., Okayama N., Shimizu M., Okouchi M., Ito S., Fukutomi T., and Itoh M. Participation of high glucose concentrations in neutrophil adhesion and surface expression of adhesion molecules on cultured human endothelial cells: effect of antidiabetic medicines. Journal of Diabetes and Its Complications 16 3 (2002) 201-208
18. Poston R.N., Haskard D.O., Coucher J.R., Gall N.P., and Johnson-Tidey R.R. Expression of intercellular adhesion molecule-1 in atherosclerotic plaque. The American Journal of Pathology 140 3 (1992) 665-673
19. Pruefer D., Scalia R., and Lefer A.M. Simvastatin inhibits leukocyte-endothelial cell interactions and protects against inflammatory processes in normocholesterolemic rats. Arteriosclerosis, Thrombosis, and Vascular Biology 19 12 (1999) 2894-2900
20. Rojas S., Rojas R., Lamperti L., Casanello P., and Sobrevia L. Hyperglycaemia inhibits thymidine incorporation and cell growth via protein kinase C, mitogen-activated protein kinases and nitric oxide in human umbilical vein endothelium. Experimental Physiology 88 2 (2003) 209-219
21. Ross R. Atherosclerosis-an inflammatory disease. The New England Journal of Medicine 340 2 (1999) 115-126
22. Rothlein R., Czajkowski M., O'Neill M.M., Marlin S.D., Mainolfi E., and Merluzzi V.J. Induction of intercellular adhesion molecule-1 on primary and continuous cell lines by pro-inflammatory cytokines. Regulation by pharmacologic agents and neutralizing antibodies. Journal of Immunology 141 5 (1988) 1665-1669
23. Ruiz-Meana M., Garcia-Dorado D., Pina P., Inserte J., Agullo L., and Soler-Soler J. Cariporide preserves mitochondrial proton gradient and delays ATP depletion in cardiomyocytes during ischemic conditions. American Journal of Physiology. Heart and Circulatory Physiology 285 3 (2003) H999-H1006
24. + antiporter, a glycoprotein of 110 kD. Science 247 4943 (1990) 723-726
25. Schmidt M.I., Duncan B.B., Bang H., Pankow J.S., Ballantyne C.M., Golden S.H., Folsom A.R., Chambless L.E., and The Atherosclerosis Risk in Communities Investigators. Identifying individuals at high risk for diabetes: The Atherosclerosis Risk in Communities study. Diabetes Care 28 8 (2005) 2013-2018
26. + exchange inhibitor cariporide as a cardioprotective drug: from the laboratory to the GUARDIAN Trial. Journal of Thrombosis and Thrombolysis 8 1 (1999) 61-70
27. Schonfeld G. Diabetes, lipoproteins, and atherosclerosis. Metabolism 34 12 Suppl. 1 (1985) 45-50
28. Selvin E., Coresh J., Golden S.H., Boland L.L., Brancati F.L., Steffes M.W., and Atherosclerosis risk in communities study. Glycemic control, atherosclerosis, and risk factors for cardiovascular disease in individuals with diabetes: the atherosclerosis risk in communities study. Diabetes Care 28 8 (2005) 1965-1973
29. Sigal R., Malcolm J., and Meggison H. Cardiovascular disease in diabetes. Clinical Evidence 7 (2002) 498-520
30. 2+ overload and prolonged acidosis on reperfusion. Circulation 101 23 (2000) 2749-2755
31. Telejko B., Tomasiak M., Stelmach H., and Kinalska I. Platelet sodium-proton exchanger and phospholipid-dependent procoagulant activity in patients with type 2 diabetes. Metabolism 52 1 (2003) 102-106
32. + exchange blockers EIPA, cariporide and eniporide. Molecular and Cellular Biochemistry 250 1-2 (2003) 47-54
33. Thomas J.A., Buchsbaum R.N., Zimniak A., and Racker E. Intracellular pH measurements in Ehrlich ascites tumor cells utilizing spectroscopic probes generated in situ. Biochemistry 18 11 (1979) 2210-2218
34. Veiraiah A. Hyperglycemia, lipoprotein glycation, and vascular disease. Angiology 56 4 (2005) 431-438
35. + exchange inhibitor prevented endothelial dysfunction induced by high glucose. Journal of Cardiovascular Pharmacology 45 6 (2005) 586-590
36. + antiport activity and gene expression in cultured vascular smooth muscle cells. Role of protein kinase C. The Journal of Clinical Investigation 93 6 (1994) 2623-2631
37. Yamagishi S., Nakamura K., and Inoue H. Possible participation of advanced glycation end products in the pathogenesis of osteoporosis in diabetic patients. Medical Hypotheses 65 6 (2005) 1013-1015
38. 2+-dependent ICAM-1 mRNA expression in human aortic endothelial cells. Biochemical and Biophysical Research Communications 322 1 (2004) 68-73